Nanotherapeutic potential in glaucoma associated ocular cancers

Puntos clave

• Nanotherapeutic strategies demonstrate effective drug delivery systems targeting ocular cancers.
• Key evidence shows enhanced treatment efficacy via nanoparticles, potentially reducing adverse effects.
• Research utilizes advanced biomarker identification to better measure treatment response in glaucoma patients.
• Nanotherapeutic methods show promise to address unmet needs in ocular cancer care, but clinical validation is essential.